Aquestive Therapeutics Inc. (AQST) Misses Q1 EPS by 8c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q1 EPS of ($0.24), $0.08 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $12.23 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Stria Lithium rebrands as Arc Mineral Royalties after gold deal
• Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald